-
DEA Delays Production Of Marijuana Drug As Potential Treatment For Multiple Sclerosis And Huntington's Disease
Monday, March 14, 2022 - 8:02am | 363MMJ International Holdings, in collaboration with a specialty pharmaceutical solutions company, has been manufacturing gelatin capsule medicines based on compounds found in cannabis. The company will investigate these in clinical trials as potential treatments for multiple sclerosis (MS) and...
-
STEM Solutions LLC Builds Federally Authorized Cannabis Lab For MMJ BioPharma Labs
Friday, February 11, 2022 - 10:43am | 364MMJ BioPharma Labs recently became one of the only federally authorized labs dedicated to cannabis extraction, research, and development with their approved DEA Analytical Lab Registration for schedule 1-4 drugs. The company's primary focus is on cannabis research and development. MMJ BioPharma...